Embedded Files
"They approached me privately and said, someday you'll get married and have a family, and it's not important that your name be on the patent"— Elizabeth Bugie (Dees 2024)
Image from Lady Science
Why was Elizabeth Bugie Marginalized?
Why was Elizabeth Bugie Marginalized?
Despite Elizabeth Bugie being recognized in the original scientific publication, her role has largely been omitted from mainstream historical narratives. Her marginalization was not due to a lack of contribution, but rather due to how scientific credit was distributed, preserved, and institutionalized over time.
Initial Recognition Followed by Erasure (Wainwright 1991)
Initial Recognition Followed by Erasure (Wainwright 1991)
At the time of the discovery, Bugie was clearly acknowledged as a contributor. She is listed as a co-author on the foundational 1944 paper on streptomycin alongside Albert Schatz and Selman Waksman (Schatz et al 1944). Early medical literature also continued to recognize this authorship, reinforcing the visibility of Bugie’s contribution in the immediate aftermath of the discovery.
However, her recognition did not continue. Over time, the narrative of streptomycin’s discovery became increasingly centred on Waksman, while Bugie’s role was minimized or omitted. These shifts demonstrate that her marginalization occurred after the discovery.
Exclusion from the Patent Record (Kingston 2004)
Exclusion from the Patent Record (Kingston 2004)
One of the strongest pieces of evidence for Bugie’s marginalization is her absence from the 1945 streptomycin patent. Patents serve as legal recognition of inventions and play a major role in shaping scientific credit; yet, Bugie was not listed as an inventor. Instead, the patent credited only Waksman and Schatz.
Bugie's exclusion is significant because patent authorship is not accidental, as it requires deliberate selection. As a result, Bugie’s omission represents a structural removal from the official record of invention, limiting both her recognition and association with the discovery in future scientific and historical accounts.
"If women's lib had been around, my name would have been on the patent"—Elizabeth Bugie (Angelova 2018)
Credit Consolidation Around Senior Scientists
Credit Consolidation Around Senior Scientists
As streptomycin gained global importance, recognition became concentrated around Waksman. Selman Waksman was awarded the Nobel Prize in 1952 for the discovery of streptomycin, further reinforcing his central role in the narrative (Woodruff 2014). In formal accounts, Bugie is not framed as a co-discoverer but rather as part of a broader group of collaborators or assistants.
Her exclusion reflects a broader pattern in scientific research during the mid-20th century, where senior male scientists were often credited as primary discoverers, while junior researchers—including women—were repositioned as supporting contributors rather than intellectual equals (Ross et al 2022).
Image from Winner of the 1952 Nobel Prize
Overshadowed by the Waksman-Schatz Dispute (Kingston 2004)
Overshadowed by the Waksman-Schatz Dispute (Kingston 2004)
Historical attention has largely focused on the dispute between Waksman and Schatz over recognition and royalties. This conflict became central to the story of streptomycin’s discovery, effectively focusing the narrative to a two-person controversy.
As a result, Bugie’s contributions were largely excluded from the discussion. Peer-reviewed historical analysis highlights that this case illustrates how scientific credit is shaped not only by contribution, but also by power, authority, and institutional control.
"For most of history, Anonymous was a woman" —Virginia Woolf (Angelova 2018)
Gender and Structural Marginalization (Norman 1998)
Gender and Structural Marginalization (Norman 1998)
Bugie’s experience is consistent with broader patterns affecting women in science during the mid-20th century. Women were frequently excluded from patents, underrepresented in leadership roles, and often characterized as technical assistants rather than independent contributors.
Additionally, Bugie states that, "They approached me privately and said, someday you'll get married and have a family, and it's not important that your name be on the patent," exemplifying clear gender marginalization by Waksman and Schatz (Dees 2024).
While direct evidence of intentional discrimination in Bugie’s case is limited, the pattern of her exclusion, particularly from the patent and later narratives, aligns with systemic gender bias in scientific institutions at the time. Her intentional exclusion suggests that her marginalization was not an isolated incident, but part of a larger structural issue within the scientific community.
The "Lone Genius" Myth (Nobel Prize Outreach 2019)
The "Lone Genius" Myth (Nobel Prize Outreach 2019)
Many scientific discoveries are often credited to a single individual, reinforcing the idea that breakthroughs come from isolated “geniuses.” However, this narrative does not fully capture how scientific discovery actually occurs.
Nobel Prize-winning scientist, Martin Chalfie, describes how this belief can be harmful. Early in his career, he thought that successful scientists should be able to solve problems entirely on their own. As a result, he avoided asking for help, struggled in the lab, and eventually stepped away from research. He later recognized that this mindset was based on a misconception. Scientific discovery is not an individual pursuit, but a collaborative process built on shared knowledge, mentorship, and teamwork. This myth can discourage emerging scientists, making them feel that needing support is a sign of failure, when in reality, collaboration is essential to progress.
Bugie's role in the discovery of streptomycin challenges the idea that discoveries are made in isolation. Working in a team of researchers studying antibiotic-producing microorganisms, she played an important role in the experimental work that led to the identification of streptomycin. Despite her role, recognition was largely given to a few individuals—Waksman and Schatz—reinforcing the lone genius narrative. Bugie's story highlights how scientific breakthroughs are built through collective effort, and why it is important to acknowledge the many contributors behind all discoveries.
Was Bugie's Marginalization Conscious or Unconscious?
Was Bugie's Marginalization Conscious or Unconscious?
Although it is difficult to determine the precise intent behind each decision, the outcome is clear: Bugie’s contributions were systematically deprioritized in the records that define scientific legacy.
Relevance Today
Relevance Today
Elizabeth Bugie was not marginalized because her work lacked importance, but because recognition in science is shaped by more than discovery alone. Her exclusion from the patent, the consolidation of credit around more powerful figures, and broader structural biases all contributed to her disappearance from the historical narrative. However, these patterns are not confined to the past, as recent research continues to show that women and underrepresented groups in science often receive less recognition (Ross et al 2022).
References
References
Dees J. 2024 Oct 14. Elizabeth Bugie Gregory: A forgotten figure in streptomycin discovery. Joyful Microbe. https://joyfulmicrobe.com/elizabeth-bugie-gregory-streptomycin/
Kingston W. 2004. Streptomycin, Schatz v. Waksman, and the balance of credit for discovery. Journal of the History of Medicine and Allied Sciences. 59(3):441–462. https://www.jstor.org/stable/24632177
Norman O. 1998. Marginalized discourses and scientific literacy. Journal of Research in Science Teaching. 35(4):365–374. https://doi.org/10.1002/(sici)1098-2736(199804)35:4%3C365::aid-tea6%3E3.0.co;2-o
Ross MB et al. 2022. Women are credited less in science than are men. Nature. 608:135–145. https://doi.org/10.1038/s41586-022-04966-w
Schatz A, Bugle E, Waksman SA. 1944. Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. Proceedings of the Society for Experimental Biology and Medicine. 55(1):66–69.
The myth of the lone genius. 2019 Nov 1. Nobel Prize Outreach; [accessed 2026 Apr 6]. https://www.nobelprize.org/martin-chalfie-npii-canada/
Wainwright M. 1991. Streptomycin: discovery and resultant controversy. History and Philosophy of the Life Sciences. 13(1):97–124. https://www.jstor.org/stable/23330620
Woodruff HB. 2014. Selman A. Waksman, Winner of the 1952 Nobel Prize for Physiology or Medicine. Applied and Environmental Microbiology. 80(1):2–8. https://doi.org/10.1128/AEM.01143-13
Page updated
Report abuse